Indication

For the prevention of vaso-occlusive complications of Sickle Cell Disease in patients over 2 years of age.

Medicine details

Medicine name:
hydroxycarbamide (Xromi)
SMC ID:
SMC2271
Pharmaceutical company
Nova Laboratories Ltd
BNF chapter
Nutrition and blood
Submission type
Full
Publication due date:
TBC
SMC meeting date:
TBC
Patient group submission deadline:
TBC